You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa – A Six Country Study
|
|---|---|
| Published in |
PLOS ONE, May 2008
|
| DOI | 10.1371/journal.pone.0002132 |
| Pubmed ID | |
| Authors |
Roger Bate, Philip Coticelli, Richard Tren, Amir Attaran |
| Abstract |
A range of antimalarial drugs were procured from private pharmacies in urban and peri-urban areas in the major cities of six African countries, situated in the part of that continent and the world that is most highly endemic for malaria. Semi-quantitative thin-layer chromatography (TLC) and dissolution testing were used to measure active pharmaceutical ingredient content against internationally acceptable standards. 35% of all samples tested failed either or both tests, and were substandard. Further, 33% of treatments collected were artemisinin monotherapies, most of which (78%) were manufactured in disobservance of an appeal by the World Health Organisation (WHO) to withdraw these clinically inappropriate medicines from the market. The high persistence of substandard drugs and clinically inappropriate artemisinin monotherapies in the private sector risks patient safety and, through drug resistance, places the future of malaria treatment at risk globally. |
Mendeley readers
The data shown below were compiled from readership statistics for 159 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 5 | 3% |
| Belgium | 1 | <1% |
| Unknown | 153 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 34 | 21% |
| Student > Ph. D. Student | 21 | 13% |
| Researcher | 16 | 10% |
| Student > Bachelor | 16 | 10% |
| Other | 9 | 6% |
| Other | 35 | 22% |
| Unknown | 28 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 43 | 27% |
| Agricultural and Biological Sciences | 24 | 15% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 8% |
| Social Sciences | 11 | 7% |
| Chemistry | 6 | 4% |
| Other | 33 | 21% |
| Unknown | 29 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 July 2013.
All research outputs
#1,363,947
of 22,660,862 outputs
Outputs from PLOS ONE
#17,951
of 193,497 outputs
Outputs of similar age
#3,048
of 78,676 outputs
Outputs of similar age from PLOS ONE
#39
of 336 outputs
Altmetric has tracked 22,660,862 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 193,497 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.0. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 78,676 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 336 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.